| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |